Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Biodexa Pharmaceuticals Plc

Biodexa Pharmaceuticals Plc (BDRX) Stock Overview

Explore Biodexa Pharmaceuticals Plc’s financial performance, market position, analyst ratings, and future outlook.

BDRX●NASDAQ
HealthcareBiotechnology
$1.30
$0.64(96.94%)
U.S. Market opens in 33h 44m

Biodexa Pharmaceuticals Plc (BDRX)

Meyka AI Score

Z

Key Financials

Market Cap969.9K
P/E Ratio-0.00
EPS (TTM)$-0.00
ROE-0.56%
Fundamental Analysis

AI Price Forecasts

1 Month$2.38
3 Months$4.32
1 Year Target$0.00

BDRX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Biodexa Pharmaceuticals Plc's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BDRX on the NASDAQ shows an RSI of 55.14, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Biodexa Pharmaceuticals Plc's NASDAQ-traded stock include a P/E ratio of -0.00 and a market capitalization of 969.9K. Combined with our AI analysis, these give both institutional and retail investors a clear view of BDRX on the NASDAQ.

Price Performance (NASDAQ: BDRX)

1-Day Change
96.94%
5-Day Change
65.86%
1-Month Change
-17.72%
3-Month Change
-57.79%
6-Month Change
-71.55%
Year-to-Date (YTD) Change
-88.55%
1-Year Change
-95.62%
3-Year Change
-99.98%
5-Year Change
-100.00%
All-Time (Max) Change
-100.00%

Contact Information

https://www.biodexapharma.com
44 29 2048 0180
1 Caspian Point, Cardiff, WA, CF10 4DQ

Company Facts

110 Employees
IPO DateDec 7, 2015
CountryGB
Actively Trading

Frequently Asked Questions